RTX

UBS has maintained a 'Hold' rating on RTX stock.

The Q1 FY2026 earnings call transcript provides direct insight into RTX's financial performance, including a strong start to 2026 with significant organic sales and adjusted operating profit growth across all business segments.

RTX narrative: Q1 FY2026 earnings Reported (Q1 FY2026)

RTX offers a diversified mix of military and commercial aerospace technologies, generating $88.6 billion in revenue for FY 2025, representing approximately 9.8% growth over the prior year.

RTX stock, despite a significant $271 billion backlog and a 19% drawdown, presents a buying opportunity due to the ongoing 'defense supercycle'.

RTX, with its diversified mix of military and commercial aerospace technologies across Collins Aerospace, Pratt & Whitney, and Raytheon segments, is a unique player less reliant on any single government program compared to peers like Lockheed Martin.

RTX's significant backlog and recent stock drawdown suggest it may be an attractive buying opportunity amidst a defense supercycle.

RTX's diversified business model across commercial and government aviation, through its Collins Aerospace, Pratt & Whitney, and Raytheon segments, offers better value than pure-play defense contractors like Lockheed Martin in 2026, driven by an anticipated 9.8% revenue growth in FY 2025 to $88.6 billion.